TL
The Longevity Fund
Micro VCActiveThe Longevity Fund finds and funds companies that aim to extend the period of healthy human life.
12
Investments
2
Exits
$100M
AUM
16.7%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for The Longevity Fund.
Investment Thesis & Strategy
The Longevity Fund invests in biotech and fintech companies across various stages that are focused on extending the healthy human lifespan. They seek companies with innovative solutions in the longevity space.
Investment Activity
Deals per year over the last 7 years
1
20160
20171
20181
20190
20203
20214
2022Portfolio Companies
Selected investments from their portfolio of 12 companies
N
NewLimit
Biotech · Series A, 2022
R
Revel Pharmaceuticals
Biotech · Seed, 2022
F
FutuRx
Biotech · Seed, 2022
D
Deep Longevity
Biotech · Growth, 2022
C
Cohere Bio
Biotech · Seed, 2021
C
CellAge
Biotech · Seed, 2021
T
Turn Biotechnologies
Biotech · Series A, 2021
I
Insitro
Biotech · Series B, 2019
B
BioAge Labs
Biotech · Series B, 2018
U
Unity Biotechnology
Biotech · Series A, 2016
Notable Exits
CompanyTypeYearValue / Acquirer
Unity BiotechnologyIPO2018$300M
Navitor PharmaceuticalsAcquisition2016—
Frequently Asked Questions
The Longevity Fund focuses on Seed, Series A stage investments.
Related Investors
SV Angel
San Francisco, United States · 922 deals
Right Side Capital Management
San Francisco, United States · 894 deals
FundersClub
San Francisco, United States · 425 deals
Slow Ventures
San Francisco, United States · 415 deals
Tuesday Capital
San Francisco, United States · 272 deals
Harrison Metal
San Francisco, United States · 202 deals